Literature DB >> 25552310

Effect of culture conditions on microRNA expression in primary adult control and COPD lung fibroblasts in vitro.

Jun Ikari1, Lynette M Smith, Amy J Nelson, Shunichiro Iwasawa, Yoko Gunji, Maha Farid, Xingqi Wang, Hesham Basma, Carol Feghali-Bostwick, Xiangde Liu, Dawn L DeMeo, Stephen I Rennard.   

Abstract

In vitro cell cultures, including lung fibroblasts, have been used to identify microRNAs (miRNAs) associated with chronic obstructive pulmonary disease (COPD) pathogenesis. However, culture conditions may affect miRNA expression. We examined whether miRNA expression in primary adult lung fibroblasts varies with cell density or passage in vitro and whether culture conditions confound the identification of altered miRNA expression in COPD lung fibroblasts. Primary adult control and COPD lung fibroblasts were cultured until passage 3 or 8, after which cells were further cultured for 3 or 7 d (low vs. high density). Then, cells at low density were cultured with serum-free media, and those at high density were cultured with serum-free media in the absence or presence of interleukin-1β (IL-1β) and tumor necrosis factor alpha (TNF-α) for 24 h. RNA was extracted to perform miRNA microarray from which 1.25-fold differential expression and 10% false discovery rate were applied to identify "invariant" and "variant" miRNA for the various culture conditions. Of the 2226 miRNAs evaluated, 39.0% for cell density, 40.7% for cell passage, and 29.4% for both conditions were identified as "invariant" miRNAs. Furthermore, 38.1% of the evaluated miRNAs were "invariant" for cell passage with IL-1β and TNF-α. Differentially expressed miRNAs between control and COPD lung fibroblasts were identified with and without IL-1β and TNF-α, and of these, 32 out of the 34 top-ranked miRNAs exceeded the differences due to culture conditions. Thus, culture conditions may affect miRNA expression of adult human lung fibroblasts. Nevertheless, in vitro cultures can be used to assess differential miRNA expression in COPD lung fibroblasts.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25552310     DOI: 10.1007/s11626-014-9820-8

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  47 in total

1.  Screening for partial conjunction hypotheses.

Authors:  Yoav Benjamini; Ruth Heller
Journal:  Biometrics       Date:  2008-02-06       Impact factor: 2.571

Review 2.  Role of MicroRNAs in lung disease.

Authors:  Martín Angulo; Emilia Lecuona; Jacob Iasha Sznajder
Journal:  Arch Bronconeumol       Date:  2012-05-17       Impact factor: 4.872

3.  Premature lung aging and cellular senescence in the pathogenesis of idiopathic pulmonary fibrosis and COPD/emphysema.

Authors:  Marco Chilosi; Angelo Carloni; Andrea Rossi; Venerino Poletti
Journal:  Transl Res       Date:  2013-07-02       Impact factor: 7.012

4.  MicroRNAs miR-146a/b negatively modulate the senescence-associated inflammatory mediators IL-6 and IL-8.

Authors:  Dipa Bhaumik; Gary K Scott; Shiruyeh Schokrpur; Christopher K Patil; Arturo V Orjalo; Francis Rodier; Gordon J Lithgow; Judith Campisi
Journal:  Aging (Albany NY)       Date:  2009-04       Impact factor: 5.682

5.  Changes in microRNA and mRNA expression with differentiation of human bronchial epithelial cells.

Authors:  Asuncion Martinez-Anton; Milena Sokolowska; Steven Kern; A Sally Davis; Sara Alsaaty; Jeffery K Taubenberger; Junfeng Sun; Rongman Cai; Robert L Danner; Michael Eberlein; Carolea Logun; James H Shelhamer
Journal:  Am J Respir Cell Mol Biol       Date:  2013-09       Impact factor: 6.914

6.  Large-scale screening identifies a novel microRNA, miR-15a-3p, which induces apoptosis in human cancer cell lines.

Authors:  Aliaksandr Druz; Yu-Chi Chen; Rajarshi Guha; Michael Betenbaugh; Scott E Martin; Joseph Shiloach
Journal:  RNA Biol       Date:  2013-01-25       Impact factor: 4.652

7.  Chronic obstructive pulmonary disease and neutrophil infiltration: role of cigarette smoke and cyclooxygenase products.

Authors:  Mirella Profita; Angelo Sala; Anna Bonanno; Loredana Riccobono; Maria Ferraro; Stefania La Grutta; Giusy Daniela Albano; Angela Marina Montalbano; Mark Gjomarkaj
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-11-06       Impact factor: 5.464

Review 8.  MicroRNAs: key regulators of stem cells.

Authors:  Vamsi K Gangaraju; Haifan Lin
Journal:  Nat Rev Mol Cell Biol       Date:  2009-02       Impact factor: 94.444

9.  Bcl-xL silencing induces alterations in hsa-miR-608 expression and subsequent cell death in A549 and SK-LU1 human lung adenocarcinoma cells.

Authors:  Norahayu Othman; Lionel L A In; Jennifer A Harikrishna; Noor Hasima
Journal:  PLoS One       Date:  2013-12-10       Impact factor: 3.240

10.  High-throughput sequencing of microRNAs in peripheral blood mononuclear cells: identification of potential weight loss biomarkers.

Authors:  Fermín I Milagro; Jonatan Miranda; María P Portillo; Alfredo Fernandez-Quintela; Javier Campión; J Alfredo Martínez
Journal:  PLoS One       Date:  2013-01-15       Impact factor: 3.240

View more
  9 in total

1.  Differential microRNA expression in cultured palatal fibroblasts from infants with cleft palate and controls.

Authors:  Christian Schoen; Jeffrey C Glennon; Shaghayegh Abghari; Marjon Bloemen; Armaz Aschrafi; Carine E L Carels; Johannes W Von den Hoff
Journal:  Eur J Orthod       Date:  2018-01-23       Impact factor: 3.075

2.  Delineating the Effects of Passaging and Exposure in a Longitudinal Study of Arsenic-Induced Squamous Cell Carcinoma in a HaCaT Cell Line Model.

Authors:  Mayukh Banerjee; Laila Al-Eryani; Sudhir Srivastava; Shesh N Rai; Jianmin Pan; Theodore S Kalbfleisch; J Christopher States
Journal:  Toxicol Sci       Date:  2022-01-24       Impact factor: 4.849

3.  Age-associated changes in microRNAs affect the differentiation potential of human mesenchymal stem cells: Novel role of miR-29b-1-5p expression.

Authors:  Nada H Eisa; Periyasamy T Sudharsan; Sergio Mas Herrero; Samuel A Herberg; Brian F Volkman; Alexandra Aguilar-Pérez; Dmitry Kondrikov; Ahmed M Elmansi; Charles Reitman; Xingming Shi; Sadanand Fulzele; Meghan E McGee-Lawrence; Carlos M Isales; Mark W Hamrick; Maribeth H Johnson; Jie Chen; William D Hill
Journal:  Bone       Date:  2021-08-14       Impact factor: 4.398

4.  Genomic comparison of early-passage conditionally reprogrammed breast cancer cells to their corresponding primary tumors.

Authors:  Akanksha S Mahajan; Bruna M Sugita; Anju N Duttargi; Francisco Saenz; Ewa Krawczyk; Justine N McCutcheon; Aline S Fonseca; Bhaskar Kallakury; Paula Pohlmann; Yuriy Gusev; Luciane R Cavalli
Journal:  PLoS One       Date:  2017-10-19       Impact factor: 3.240

Review 5.  Inhaled RNA Therapeutics for Obstructive Airway Diseases: Recent Advances and Future Prospects.

Authors:  You Xu; Aneesh Thakur; Yibang Zhang; Camilla Foged
Journal:  Pharmaceutics       Date:  2021-01-28       Impact factor: 6.321

Review 6.  Molecular Background of miRNA Role in Asthma and COPD: An Updated Insight.

Authors:  Izabela Szymczak; Joanna Wieczfinska; Rafal Pawliczak
Journal:  Biomed Res Int       Date:  2016-06-08       Impact factor: 3.411

7.  Reduced microRNA-503 expression augments lung fibroblast VEGF production in chronic obstructive pulmonary disease.

Authors:  Jun Ikari; Amy J Nelson; Jannah Obaid; Alvaro Giron-Martinez; Kumiko Ikari; Fumihiko Makino; Shunichiro Iwasawa; Yoko Gunji; Maha Farid; Xingqi Wang; Hesham Basma; Dawn Demeo; Carol Feghali-Bostwick; Olaf Holz; Klaus Rabe; Xiangde Liu; Stephen I Rennard
Journal:  PLoS One       Date:  2017-09-07       Impact factor: 3.240

8.  Identification of Endogenous Control miRNAs for RT-qPCR in T-Cell Acute Lymphoblastic Leukemia.

Authors:  Monika Drobna; Bronisława Szarzyńska-Zawadzka; Patrycja Daca-Roszak; Maria Kosmalska; Roman Jaksik; Michał Witt; Małgorzata Dawidowska
Journal:  Int J Mol Sci       Date:  2018-09-20       Impact factor: 5.923

9.  Marked TGF-β-regulated miRNA expression changes in both COPD and control lung fibroblasts.

Authors:  J Ong; A Faiz; W Timens; M van den Berge; M M Terpstra; K Kok; A van den Berg; J Kluiver; C A Brandsma
Journal:  Sci Rep       Date:  2019-12-03       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.